LabCompass

Publications

53

Citations

2,179

Est. group size

Recurring co-author estimate

Active years

39

Publishing since 1988

Research summary
AI-generated

Hongde Li studies the molecular and metabolic mechanisms that drive cancer, with a focus on how tumor cells reprogram metabolism (for example, arginine and polyamine pathways) and how signaling proteins such as the Hippo pathway effectors YAP/TAZ control cell growth. The work spans breast cancer, lung cancer, and interactions between tumor cells and immune cells in the surrounding tissue environment. Related projects touch on RNA modifications, cell proliferation signaling, and mass-spectrometry-based measurement of small molecules (metabolomics).

Cancer metabolism and metabolic reprogrammingTumor microenvironment and immune evasionHippo/YAP signaling in cell growthCell proliferation and mitotic signalingMetabolomics and mass spectrometry

Publication activity has been steady, averaging about four papers per year over the last five years after a dip around 2020–2021.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.0/year recently
2017: 7 publications172018: 8 publications8182019: 4 publications192020: 3 publications20212022: 5 publications222023: 4 publications232024: 4 publications242025: 6 publications252026: 1 publication26
Recent publications
Publishes in
  • bioRxiv (Cold Spring Harbor Laboratory)×6
  • Cancer Cell×2
  • Journal of Biological Chemistry×2
  • Journal of Visualized Experiments×2
  • Cancer Biology and Medicine×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile